Sonoma Pharmaceuticals (SNOA) Operating Expenses: 2010-2012
Historic Operating Expenses for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $3.2 million.
- Sonoma Pharmaceuticals' Operating Expenses fell 25.08% to $3.2 million in Q4 2012 from the same period last year, while for Dec 2012 it was $14.1 million, marking a year-over-year decrease of 5.03%. This contributed to the annual value of $15.2 million for FY2012, which is 11.25% up from last year.
- According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Operating Expenses is $3.2 million, which was down 21.56% from $4.0 million recorded in Q3 2012.
- Sonoma Pharmaceuticals' 5-year Operating Expenses high stood at $4.2 million for Q4 2011, and its period low was $3.2 million during Q4 2012.
- Its 3-year average for Operating Expenses is $3.6 million, with a median of $3.4 million in 2011.
- As far as peak fluctuations go, Sonoma Pharmaceuticals' Operating Expenses skyrocketed by 30.34% in 2011, and later dropped by 25.08% in 2012.
- Sonoma Pharmaceuticals' Operating Expenses (Quarterly) stood at $3.2 million in 2010, then soared by 30.34% to $4.2 million in 2011, then dropped by 25.08% to $3.2 million in 2012.
- Its Operating Expenses stands at $3.2 million for Q4 2012, versus $4.0 million for Q3 2012 and $3.4 million for Q2 2012.